ANI Pharmaceuticals, Inc. (ANIP)
$73.89+2.65%Close
SELLRECOVERY · day 46
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.7B
- Beta
- 0.49
- P/E (TTM)
- 14.81
- Short % float
- 17.98%
- Days to cover
- 7.2
- SI change
- +40.2%
- 1W
- +2.37%
- 1M
- +3.40%
- vs SPY 1W
- +1.21%
- vs SPY 1M
- +0.41%
Industry peers
FMP comparable companies · ranked by market cap
- TEVABUYTeva Pharmaceutical Industries Limited$47.9BBULLQ 13$41.10+4.71%
- VTRSBUYViatris Inc.$20.5BBULLQ 5$17.64+1.15%
- RDYBUYDr. Reddy's Laboratories Limited$10.4BRECOVERYQ 16$12.48+2.30%
- AMRXBUYAmneal Pharmaceuticals, Inc.$6.4BBULLQ 15$19.91+1.32%
- BHCSELLBausch Health Companies Inc.$2.3BRECOVERYQ 2$6.04+0.00%
- AMPHBUYAmphastar Pharmaceuticals, Inc.$1.2BRECOVERYQ 9$26.62+3.14%
- HROWSELLHarrow Health, Inc.$1.1BCRISISQ 14$29.36-3.80%
- COLLSELLCollegium Pharmaceutical, Inc.$716MBEARQ 14$22.09-0.09%
- EOLSSELLEvolus, Inc.$509MBEARQ 10$7.73-0.90%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on ANIP?
- LOPJLB’s latest quantitative signal on ANI Pharmaceuticals, Inc. (ANIP) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is ANIP in?
- ANI Pharmaceuticals, Inc. (ANIP) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does ANI Pharmaceuticals, Inc. (ANIP) do?
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and po…